Clinical Trial Update: Bioavailability in Patient With Psoriasis: Metoject Prefilled Pen [Phase 1]

View source ↗

Summary

Phase 1 trial assessing bioavailability of Metoject Prefilled Pen in a patient with psoriasis; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Metoject Prefilled Pen (methotrexate)

Snippet

Sponsor: medac GmbH | Conditions: Psoriasis | Phase 1 | Status: COMPLETED